AFL vs ALKS · P/E 14, rev $18.93B vs P/E 14, rev $1.56B
Aflac Incorporated (AFL) versus Alkermes Plc (ALKS) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AFL revenue for 2024-12-31 was $18.93B. Net income was $5.44B. Revenue was up 401.1% from 2023-12-31 to 2024-12-31. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Not investment advice. Open the AFL and ALKS stock pages for the full models.
Not investment advice.